Bluejay Total Liab from 2010 to 2024

BJDX Stock  USD 3.48  0.14  3.87%   
Bluejay Diagnostics Total Liabilities yearly trend continues to be fairly stable with very little volatility. Total Liabilities is likely to outpace its year average in 2024. Total Liabilities is the total amount of all liabilities that Bluejay Diagnostics has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2010-12-31
Previous Quarter
M
Current Value
2.3 M
Quarterly Volatility
1.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bluejay Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluejay Diagnostics' main balance sheet or income statement drivers, such as Net Interest Income of 173.1 K, Depreciation And Amortization of 820 K or Interest Expense of 22.8 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0 or PTB Ratio of 24.26. Bluejay financial statements analysis is a perfect complement when working with Bluejay Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Bluejay Diagnostics Correlation against competitors.
For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.

Latest Bluejay Diagnostics' Total Liab Growth Pattern

Below is the plot of the Total Liab of Bluejay Diagnostics over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Bluejay Diagnostics' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bluejay Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Bluejay Total Liab Regression Statistics

Arithmetic Mean3,404,669
Geometric Mean3,096,263
Coefficient Of Variation35.44
Mean Deviation901,561
Median3,848,956
Standard Deviation1,206,640
Sample Variance1.5T
Range5.1M
R-Value(0.51)
Mean Square Error1.2T
R-Squared0.27
Significance0.05
Slope(138,928)
Total Sum of Squares20.4T

Bluejay Total Liab History

20242.3 M
2023M
2022M
2021637.2 K
20205.7 M

About Bluejay Diagnostics Financial Statements

Bluejay Diagnostics investors use historical fundamental indicators, such as Bluejay Diagnostics' Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bluejay Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total LiabilitiesM2.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bluejay Stock Analysis

When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.